Recombinant CD47 (Magrolimab Biosimilar) antibody

Catalog No. ABIN7597807

The Humanized Chimeric anti-CD47 (Magrolimab Biosimilar) antibody has been validated for . It is suitable to detect CD47 (Magrolimab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD47 (Magrolimab Biosimilar) antibody (ABIN7597807)

Target: CD47 (Magrolimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD47 (Magrolimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD47 (Magrolimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Magrolimab Biosimilar Antibody

Specificity: Leukocyte surface antigen CD47, CD47, Antigenic surface determinant protein OA3, IAP, Integrin-associated protein, Protein MER6, MER6

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 3.65 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD47 (Magrolimab Biosimilar)

Target: CD47 (Magrolimab Biosimilar)

Alternative Name: Magrolimab Biosimilar

Target Type: Biosimilar

Background: Leukocyte surface antigen CD47, CD47, Antigenic surface determinant protein OA3, IAP, Integrin-associated protein, Protein MER6, MER6

UniProt: Q08722

CAS-No: 2169232-81-7